The collapse in value of many biotechs over the past few years has created an opportunity for specialists like Xoma to “do ...

After an earlier rejection that drew criticism from some observers, the FDA quickly accepted Stealth BioTherapeutics’ new ...

After a tumultuous two-day meeting marked by confusion and missteps, an advisory committee endorsed guidelines that would ...

Members of ACIP voted to table a planned vote on withholding some infants’ first hepatitis B vaccine dose, adding more ...

Pfizer and Arvinas plan to out-license their partnered drug vepdegestrant. Elsewhere, Novo shared more data for oral Wegovy ...

Thanks to a partnership with Ionis Pharmaceuticals, Biogen has a long history with antisense oligonucleotides, which can modify the production of proteins in the body. The two companies developed the ...

The committee reconvened Friday to re-do a vote on coverage of the combined MMRV shot through the Vaccines for Children ...

T.Rx Capital was co-founded by Michael Langer, former Pear Therapeutics CEO Corey McCann and Eli Lilly veteran Kwesi Frimpong ...

Roche’s CEO claimed 89bio’s drug, which is in late-stage testing, has the potential to show “best-in-disease efficacy” for ...

Susan Monarez told Senators at a hearing Wednesday that Robert F. Kennedy Jr. pushed her out for refusing to rubber-stamp ...

A drug licensed from Pfizer will be submitted to the FDA next year after study results showed it reduced dermatomyositis ...